MIM
ROIV icon

Monashee Investment Management’s Roivant Sciences ROIV Stock Holding History

Monashee Investment Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-303,575
Closed -$3.5M – 92
2024
Q3 		$3.5M Hold
303,575
– – 0.38% 37
2024
Q2 		$3.21M Sell
303,575
-46,425
-13% -$509K 0.41% 33
2024
Q1 		$3.69M Hold
350,000
– – 0.44% 40
2023
Q4 		$3.93M Sell
350,000
-200,000
-36% -$1.95M 0.69% 15
2023
Q3 		$6.42M Buy
550,000
+150,000
+38% +$1.7M 2.68% 7
2023
Q2 		$4.03M Sell
400,000
-100,000
-20% -$894K 0.96% 20
2023
Q1 		$3.69M Buy
500,000
+30,000
+6% +$247K 1.02% 22
2022
Q4 		$3.76M Buy
+470,000
New +$2.61M 1.62% 21

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Monashee Investment Management's ROIV Position: Q4 2024 in Review

Monashee Investment Management sold out of Roivant Sciences (ROIV) in Q4 2024, closing a stake of 303,575 shares — an estimated $3.5M sold.

Monashee Investment Management first reported a position in ROIV in Q4 2022 and held it in 8 quarters. The position peaked at $6.42M in Q3 2023. 318 funds tracked by Wall St. Rank hold ROIV as of Q4 2024.

  • Monashee Investment Management reported no remaining Roivant Sciences position as of Q4 2024 after selling out during the quarter.
  • Monashee Investment Management sold 303,575 Roivant Sciences shares in Q4 2024, an estimated $3.5M.
  • Monashee Investment Management first reported a position in Roivant Sciences in Q4 2022 and held it in 8 quarters.
  • Monashee Investment Management's Roivant Sciences position peaked at $6.42M in Q3 2023.
  • 318 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2024.

Based on Monashee Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.